Several controversial issues, as per the industry sources, including pricing of patented drugs, rationalisation of trade margins, adopting a uniform code of practices and patient support programmes were discussed. Officials from the Department of Pharmaceuticals and National Pharmaceutical Pricing Authority led the talks., Several controversial issues, as per the industry sources, including pricing of patented drugs, rationalisation of trade margins, adopting a uniform code of practices and patient support programmes were discussed. Officials from the Department of Pharmaceuticals and National Pharmaceutical Pricing Authority led the talks., , Read More

AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way